Abstract Title:

Aptamer-conjugated and doxorubicin-loaded grapefruit-derived nanovectors for targeted therapy against HER2breast cancer.

Abstract Source:

J Drug Target. 2019 May 28:1-22. Epub 2019 May 28. PMID: 31134823

Abstract Author(s):

Zhuang Tang, Yali Jun, Yanguan Lv, Yunjie Li, Zhen Zhang, Mingyue Tao, Xiaofei Chen, Jingdong He, Li Zhang, Qi-Long Wang

Article Affiliation:

Zhuang Tang


Increased human epidermal growth factor receptor 2 (HER2) expression is a hallmark of HER2breast cancer. HER2 promotes the growth of cancer cells and makes them particularly aggressive. Currently, trastuzumab is the only HER2-targeted therapeutic agent approved by the FDA for HER2-overexpressing breast cancer treatment. However, clinical efficacy of trastuzumab is limited greatly by the occurrence of drug resistance. In this study, an aptamer (HA1) specific for HER2-overexpressing breast cancer cells was selected using Cell-SELEX. This allowed the development of grapefruit-derived nanovectors (GNVs) conjugated with HA1 that targeted specifically HER2breast cancer cells. In vitro experiments demonstrated that HA1 effectively promoted the internalization of GNVs into cancer cells and tumor spheroids. In vivo data showed that drug delivery to tumor tissues and antitumor activities were dramatically enhanced by conjugating HA1 with drug-loaded GNVs. This study indicates that aptamers mediating targeted drug delivery by GNVs represent a promising strategy for HER2breast cancer therapy.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.